<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">4372178</PMID><DateCompleted><Year>1975</Year><Month>02</Month><Day>04</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>26</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0019-9567</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>4</Issue><PubDate><Year>1974</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Infection and immunity</Title><ISOAbbreviation>Infect Immun</ISOAbbreviation></Journal><ArticleTitle>Comparison of antibodies against different viruses in cerebrospinal fluid and serum samples from patients with multiple sclerosis.</ArticleTitle><Pagination><StartPage>688</StartPage><EndPage>694</EndPage><MedlinePgn>688-94</MedlinePgn></Pagination><Abstract><AbstractText>The occurrence of a local production in the central nervous system (CNS) of antibodies against different selected viruses was analyzed by comparison of titers in serum and cerebrospinal fluid samples from groups of 50 patients with multiple sclerosis from Finland, Norway, and Sweden. Measles antibodies were determined in hemagglutination inhibition, hemolysis inhibition, and nucleocapsid complement fixation tests; mumps, parainfluenza virus type 1, and rubella virus antibodies were determined in hemagglutination inhibition tests; and herpes simplex virus type 1 antibodies were determined in passive hemagglutination tests. For reference purposes tests were also made for adenovirus antibodies in penton hemagglutination enhancement tests and poliovirus antibodies in neutralization enhancement tests. Among the 150 multiple sclerosis patients, a local production of antibodies against measles virus was found in the CNS in 57%, against rubella virus in 19%, mumps virus in 15%, herpes simplex virus type 1 in 11%, and parainfluenza virus type 1 (Sendai) in 3%. A local production in the CNS of antibodies against any of the viruses studied was found in 71% of multiple sclerosis patients. These included 48, 16, and 7% that produced antibodies to one, two, and three or more viruses, respectively.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Norrby</LastName><ForeName>E</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Link</LastName><ForeName>H</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Olsson</LastName><ForeName>J E</ForeName><Initials>JE</Initials></Author><Author ValidYN="Y"><LastName>Panelius</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Salmi</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Vandvik</LastName><ForeName>B</ForeName><Initials>B</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Infect Immun</MedlineTA><NlmUniqueID>0246127</NlmUniqueID><ISSNLinking>0019-9567</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000256" MajorTopicYN="N">Adenoviridae</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005387" MajorTopicYN="N" Type="Geographic">Finland</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008459" MajorTopicYN="N">Measles virus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009103" MajorTopicYN="N">Multiple Sclerosis</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009109" MajorTopicYN="N">Mumps virus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009664" MajorTopicYN="N" Type="Geographic">Norway</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017955" MajorTopicYN="N">Poliovirus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018108" MajorTopicYN="N">Respirovirus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012412" MajorTopicYN="N">Rubella virus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018139" MajorTopicYN="N">Simplexvirus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013548" MajorTopicYN="N" Type="Geographic">Sweden</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1974</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1974</Year><Month>10</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1974</Year><Month>10</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>1974</Year><Month>10</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">4372178</ArticleId><ArticleId IdType="pmc">PMC423007</ArticleId><ArticleId IdType="doi">10.1128/iai.10.4.688-694.1974</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Proc Soc Exp Biol Med. 1967 May;125(1):162-7</Citation><ArticleIdList><ArticleId IdType="pubmed">6027517</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Soc Exp Biol Med. 1970 Jul;134(3):889-95</Citation><ArticleIdList><ArticleId IdType="pubmed">4317265</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Soc Exp Biol Med. 1971 Jul;137(3):956-61</Citation><ArticleIdList><ArticleId IdType="pubmed">4934707</ArticleId></ArticleIdList></Reference><Reference><Citation>Res Publ Assoc Res Nerv Ment Dis. 1971;49:112-55</Citation><ArticleIdList><ArticleId IdType="pubmed">4107848</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Neurol. 1972;7(1):74-8</Citation><ArticleIdList><ArticleId IdType="pubmed">5019156</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 1972 Jun 3;1(7762):1240-1</Citation><ArticleIdList><ArticleId IdType="pubmed">4113225</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Soc Exp Biol Med. 1972 Sep;140(4):1460-6</Citation><ArticleIdList><ArticleId IdType="pubmed">4341565</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 1972 May;22(5):492-9</Citation><ArticleIdList><ArticleId IdType="pubmed">4673445</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Immun. 1972 Sep;6(3):240-7</Citation><ArticleIdList><ArticleId IdType="pubmed">4118046</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Neurol Scand. 1973;49(1):85-107</Citation><ArticleIdList><ArticleId IdType="pubmed">4684595</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Neurol. 1973 Apr;28(4):278-9</Citation><ArticleIdList><ArticleId IdType="pubmed">4688434</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1973 Apr;70(4):1060-3</Citation><ArticleIdList><ArticleId IdType="pubmed">4515604</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Soc Exp Biol Med. 1973 Jul;143(3):828-9</Citation><ArticleIdList><ArticleId IdType="pubmed">4352535</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 1973 Oct 13;2(7833):847-8</Citation><ArticleIdList><ArticleId IdType="pubmed">4126643</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 1973 Nov 22;289(21):1103-7</Citation><ArticleIdList><ArticleId IdType="pubmed">4356853</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 1973 Dec 1;2(7840):1221-5</Citation><ArticleIdList><ArticleId IdType="pubmed">4128558</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Neurol. 1974 Apr;30(4):285-92</Citation><ArticleIdList><ArticleId IdType="pubmed">4131598</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Soc Exp Biol Med. 1962 Dec;111:562-6</Citation><ArticleIdList><ArticleId IdType="pubmed">14011000</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 1964 Aug 28;145(3635):943-5</Citation><ArticleIdList><ArticleId IdType="pubmed">14163822</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann N Y Acad Sci. 1965 Mar 31;122:552-68</Citation><ArticleIdList><ArticleId IdType="pubmed">14313512</ArticleId></ArticleIdList></Reference><Reference><Citation>Nord Med. 1956 May 17;55(20):693-5</Citation><ArticleIdList><ArticleId IdType="pubmed">13334950</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>